Tag Archives: STI571

by | February 5, 2010

CML – NICE – epetition response – Dasatinib (DS) & Nilotinib (NL)

Just a quick post to show the reply to 10 Downing Street’s latest reply to the Dasatinib and Nilotinib petiton and challenge to acceptance as 2nd line therapy for resistant / intolerant Imatinib (aka Glivec, Gleevec). I am not going … Continue reading →

Leave a Comment

Filed under chronic myeloid leukaemia, gleevec, glivec, imatinib, leukaemia, leukaemia research

Tagged as , , , , , , , , , , , , ,

by | February 3, 2010

Understanding CML, Glivec, PCR results and where I fit in.

I have many questions asked around what is Chronic Myeloid Leukaemia (CML), Glivec (aka. Gleevec, Imatinib, STI571) what are my results and how are they measured. Dr Brian J Druker whom was instrumental in the development of Glivec did a … Continue reading →

7 Comments

Filed under chronic myeloid leukaemia, gleevec, glivec, imatinib, leukaemia, leukaemia & lymphoma research

Tagged as , , , , , , , , , , , , , , , , , , ,